The Food and Drug Administration has announced that the Risk Evaluation and Mitigation Strategy (REMS) for transmucosal immediate-release fentanyl (TIRF) medications has been updated to better ensure the safe use of these products.
The use of non-opioid analgesic therapies is increasing among ED physicians.
Trevena has submitted their New Drug Application to the FDA for Olinvo, an oliceridine injection, for the management of moderate-to-severe pain in the hospital and similar settings.
Similar efficacy, superior safety of nonparticulate vs particulate corticosteroids for alleviating radicular pain.
At this year’s meeting, several studies presented non-opioid alternatives for pain management.
Need to expand access to non-opioid therapies
Despite evidence on the benefits of high-frequency spinal cord stimulation for the treatment of chronic pain, leading medical insurance provider holds coverage in 2 states.
